Ignite Creation Date:
2025-12-24 @ 4:50 PM
Ignite Modification Date:
2025-12-28 @ 1:24 AM
Study NCT ID:
NCT04501250
Status:
COMPLETED
Last Update Posted:
2020-08-06
First Post:
2020-08-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Comparative Study of Rinsulin® NPH, Suspension for Subcutaneous Administration, 100 IU/ml (GEROPHARM LLC, Russia) and Humulin® NPH, Suspension for Subcutaneous Administration, 100 IU/ml (Lilly France, France) Using the Euglycemic Hyperinsulinemic Clamp Method
Sponsor:
Geropharm
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-10-23
Start Date Type:
ACTUAL
Primary Completion Date:
2018-01-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-05-21
Completion Date Type:
ACTUAL
First Submit Date:
2020-08-03
First Submit QC Date:
None
Study First Post Date:
2020-08-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-08-03
Last Update Post Date:
2020-08-06
Last Update Post Date Type:
ACTUAL